Phase 2 N=37 Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver
Fatty Liver
Primary: Number of Participants With Improvement of >= 2 Points in NAFLD Activity Score (NAS) — 8; 9 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=414 Augment® Bone Graft (Formerly GEM OS™1 Bone Graft) Compared to Autologous Bone Graft in Foot and Ankle Fusions
Foot Fusion
Primary: Subjects Fused at 24 Weeks (as Determined by CT Assessment) — 85; 159 Participants
Phase 4 N=15 Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD
Attention-deficit/Hyperactivity Disorder · Autism Spectrum Disorder
Primary: Change in Adult ADHD Investigator Symptom Report Scale (AISRS) Score — -22.8 units on a scale
N/A N=4 Visuomotor Rehabilitation Training for Manual Task Deficits From Macular Scotomas
Scotoma, Central · Central Visual Impairment
Primary: Improvement in Eye-hand Coordination — 42.8; 45.4; 30.4; 71.0 Percentage
Phase 3 N=22 Study of Ibuprofen Effects on Brain Function
Major Depressive Disorder
Primary: Dose-dependent Differences in the BOLD Response to fMRI Tasks in the Amygdala — 0.20; 0.21; 0.23; 0.23 percent signal change — p=0.512
N/A N=60 Evaluation of Electrocardiographic Guidance in Accurate Peripherally Inserted Central Catheter Placement in Children.
Venous Insufficiency
Primary: Number of Participants With Successful Placement of Peripherally Inserted Central Catheter (PICC) — 40; 14; 8; 18 Participants
Phase 1 N=15 A Phase I Study to Assess PK of AZD7986 Alone & With Verapamil, Itraconazole or Diltiazem in Healthy Subjects
Healthy Subjects
Primary: Effect of Verapamil and the Effect of Itraconazole on the PK of AZD7986 by Assessment of the Observed Maximum Plasma Concentration (Cmax). — 385.8; 591.9; 234.1 nmol/L
Phase 3 N=222 A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Hypogonadism
Primary: Number of Oral TU Treated Subjects Who Have a Total T Cavg in the Eugonadal Range of 252 to 907 ng/dL at Visit 7 — 145; 48 Participants
Phase 4 N=7 Long Acting Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Young Children
Attention Deficit Hyperactivity Disorder
Primary: Change in Attention Deficit Hyperactivity Disorder Rating Scale-IV Parent Version Investigator-Scored (ADHD-IV-Parent: Inv) Total Score. — -20.1 units on a scale
N/A N=75 Peak(R) vs. Electrocautery in Children Undergoing Tonsillectomy With Adenoidectomy
Sleep Disordered Breathing
Primary: Pain Control Assessed by Validated Pain Scores: Days to Having no Pain Following Surgery — 7.0; 9.0 Days
Phase 2 N=12 Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1
Neimann-Pick Disease
Primary: Number of Participants With Tolerabilty of 200 mg Vorinostat in Niemann-Pick Disease, Type C1 — 12 Participants
N/A N=388 Efficiency of the King Vision Video Laryngoscope
Respiratory Failure · Intubation
Primary: Intubation Success Rate — 22; 13; 366; 375 participants — p=0.119
N/A N=156 Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring Systems
Diabetes Mellitus, Type 1 · Diabetes Mellitus, Type 2
Primary: The Device Performance Was Evaluated in Terms of Point Accuracy of the Abbott Sensor Based Glucose Monitoring Systems in Reference to Yellow Spring Instrument (YSI)…
Phase 2 N=85 Study of AR-13324 in Patients With Elevated Intraocular Pressure
Ocular Hypertension · Open Angle Glaucoma
Primary: Intraocular Pressure (IOP) — 25.80; 26.02; 26.50; 25.17 mmHg
N/A N=60 Assessment of Infection Control, Practice Efficiency, and Health Economics of Sheathed Versus Standard Cystoscopy
Bacteriuria
Primary: Number of Participants Who Had Post-Procedure Bacteriuria — 0; 1 Participants